Sugi Predict

Sugi Predict / Compounds / Galantide

Galantide

Galantide

SCHEMBL31332196

CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(N)=O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ IL23R Q5VWK5 1/20 0.62
▸ NMBR P28336 1/20 0.62
▸ GRPR P30550 1/20 0.62
▸ GALR2 O43603 1/20 0.61
▸ GALR1 P47211 1/20 0.61
▸ GLP1R P43220 9/20 0.61
▸ GCGR P47871 3/20 0.61
▸ CXCL8 P10145 2/20 0.61
▸ CCKBR P32239 4/20 0.59
▸ GIPR P48546 6/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29973367 0.97 CXCL8 (0.62) IL23RNMBRGRPRGALR2GALR1
SCHEMBL30429448 0.89 GALR2 (0.62) GALR2GALR1GLP1RCXCL8CCKBR
SCHEMBL30973903 0.89 NPY1R (0.66) IL23RGLP1RGCGRGIPR
SCHEMBL31061583 0.88 GALR2 (0.65) GALR2GALR1GLP1RGIPR
SCHEMBL30429251 0.88 CALCA (0.62) GALR2GALR1GLP1R
SCHEMBL29972944 0.88 NPY1R (0.69) IL23RGLP1RGCGRGIPR
SCHEMBL30429667 0.87 NMBR (0.60) NMBRGRPRGALR2GALR1GLP1R
SCHEMBL30041162 0.87 CALCA (0.64) GALR2GALR1GLP1RGCGRGIPR
SCHEMBL29370578 0.86 NPY1R (0.67) IL23RGLP1RGCGRGIPR
SCHEMBL31182464 0.85 GLP1R (0.62) GLP1RCXCL8GIPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240374689-A1 HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME LONGEVITY BIOTECH, INC. 2024-11-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240374689-A1 HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME SCTR, GIPR, APLNR IL23R 305/4885NMBR 224/4885GRPR 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback